Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross margin | 94.5% | 93.7% | 94.4% | 93.0% | 91.1% | 86.1% | 91.1% | 94.3% | 81.7% | 89.3% | 89.5% | 87.8% | 87.6% | 88.9% | 86.6% | 86.8% | 88.1% | 88.1% | 87.9% | 87.2% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Gross margin is 86.1%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Gross margin for Vertex Pharmaceuticals Incorporated have been 87.6% over the past three years, and 91.9% over the past five years.
As of today, Vertex Pharmaceuticals Incorporated's Gross margin is 86.1%, which is higher than industry median of 65.9%. It indicates that Vertex Pharmaceuticals Incorporated's Gross margin is Good.